Therapist Guided, Parent-led, Cognitive Behavioural Therapy (CBT) for Preadolescent Children With Obsessive Compulsive Disorder (OCD)
NCT ID: NCT05981690
Last Updated: 2023-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2021-06-06
2022-03-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Specifically, this study aims to:
1. Examine outcomes for children who receive the therapist guided, parent-led, CBT treatment for preadolescent children with OCD.
2. Examine parents' experiences and views about the acceptability of the treatment approach.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Internet-delivered CBT for Adolescents With OCD: A Randomized Controlled Study
NCT02191631
iCBT for Children and Adolescents With Obsessive-compulsive Disorder
NCT02973932
iCBT for Children and Adolescents With Obsessive-compulsive Disorder II
NCT05037344
ICBT for OCD in Children With Autism
NCT06582225
Process and Outcomes in CBT for Anxious and Depressed Youth
NCT03100279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This preliminary study aims to examine the outcomes from a therapist guided, parent-led, CBT treatment for preadolescent children (aged 5 to 12 years old) with OCD.
Specifically, this study aims to:
1. Examine outcomes for children who receive the therapist guided, parent-led, CBT treatment for preadolescent children with OCD.
2. Examine parents' experiences and views about the acceptability of the treatment approach.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Therapist guided, parent-led CBT for preadolescent children with OCD
6 to 8 sessions of therapist guided, parent-led CBT for preadolescent children with OCD
Therapist guided, parent-led CBT for preadolescent children with OCD
This treatment was adapted from an existing evidence based therapist guided parent-led CBT intervention for preadolescent children with anxiety difficulties. It consists of 6 to 8 treatment individual treatment sessions where parents learn CBT techniques to apply at home with their child
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Therapist guided, parent-led CBT for preadolescent children with OCD
This treatment was adapted from an existing evidence based therapist guided parent-led CBT intervention for preadolescent children with anxiety difficulties. It consists of 6 to 8 treatment individual treatment sessions where parents learn CBT techniques to apply at home with their child
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Aged 5 to 12 years old (when parents/carers complete the baseline questionnaires).
2. Diagnosis of OCD (identified from the ADIS-P).
3. UK-resident. Parents
1. Parent/legal guardian of the child.
2. UK resident.
Exclusion Criteria
1. Comorbid condition, which is likely to interfere with treatment delivery, for example:
1. Established Autism Spectrum Condition (ASC).
2. Suspected ASC (indicated by exceeding the threshold of 15 on the Social Communication Questionnaire and where a diagnosis of ASC has not been ruled out by a medical professional).
3. Profound learning difficulty (evidenced by attending a specialist school).
2. Risk and/or safeguarding concerns, which are paramount and would interfere with treatment delivery, for example:
1. Suicidal intent.
2. Recurrent or potentially life limiting self-harm.
3. Significant safeguarding concerns (i.e., if the child has a child protection plan and/or is on the child protection register, and/or the research team consider the child to be suffering, or likely to suffer, significant harm).
3. If children have been prescribed psychotropic medication, the dosage must have been stable for two months.
4. Children who are currently receiving other psychological support/interventions delivered by a mental health professional.
Parents
1. Significant intellectual impairment that is likely to interfere with treatment delivery.
2. Unable to access or understand written English language materials needed for the intervention.
5 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Reading
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kate Harvey
Professor Kate Harvey
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kate N Harvey, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Reading
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Reading
Reading, UK, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UREC 21/27
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.